These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33676240)

  • 21. The microbiome landscape in pediatric Crohn's disease and therapeutic implications.
    Fetter K; Weigel M; Ott B; Fritzenwanker M; Stricker S; de Laffolie J; Hain T
    Gut Microbes; 2023 Dec; 15(2):2247019. PubMed ID: 37614093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease.
    Mottawea W; Chiang CK; Mühlbauer M; Starr AE; Butcher J; Abujamel T; Deeke SA; Brandel A; Zhou H; Shokralla S; Hajibabaei M; Singleton R; Benchimol EI; Jobin C; Mack DR; Figeys D; Stintzi A
    Nat Commun; 2016 Nov; 7():13419. PubMed ID: 27876802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysbiotic microbiota interactions in Crohn's disease.
    Caparrós E; Wiest R; Scharl M; Rogler G; Gutiérrez Casbas A; Yilmaz B; Wawrzyniak M; Francés R
    Gut Microbes; 2021; 13(1):1949096. PubMed ID: 34313550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for bacterial urease in gut dysbiosis and Crohn's disease.
    Ni J; Shen TD; Chen EZ; Bittinger K; Bailey A; Roggiani M; Sirota-Madi A; Friedman ES; Chau L; Lin A; Nissim I; Scott J; Lauder A; Hoffmann C; Rivas G; Albenberg L; Baldassano RN; Braun J; Xavier RJ; Clish CB; Yudkoff M; Li H; Goulian M; Bushman FD; Lewis JD; Wu GD
    Sci Transl Med; 2017 Nov; 9(416):. PubMed ID: 29141885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.
    Santana PT; Rosas SLB; Ribeiro BE; Marinho Y; de Souza HSP
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.
    Liguori G; Lamas B; Richard ML; Brandi G; da Costa G; Hoffmann TW; Di Simone MP; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    J Crohns Colitis; 2016 Mar; 10(3):296-305. PubMed ID: 26574491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment-naive microbiome in new-onset Crohn's disease.
    Gevers D; Kugathasan S; Denson LA; Vázquez-Baeza Y; Van Treuren W; Ren B; Schwager E; Knights D; Song SJ; Yassour M; Morgan XC; Kostic AD; Luo C; González A; McDonald D; Haberman Y; Walters T; Baker S; Rosh J; Stephens M; Heyman M; Markowitz J; Baldassano R; Griffiths A; Sylvester F; Mack D; Kim S; Crandall W; Hyams J; Huttenhower C; Knight R; Xavier RJ
    Cell Host Microbe; 2014 Mar; 15(3):382-392. PubMed ID: 24629344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evidence for fungus in Crohn's disease pathogenesis.
    Miyoshi J; Sofia MA; Pierre JF
    Clin J Gastroenterol; 2018 Dec; 11(6):449-456. PubMed ID: 30027368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Distinct Gut Microbiota Exists Within Crohn's Disease-Related Perianal Fistulae.
    Haac BE; Palmateer NC; Seaton ME; VanYPeren R; Fraser CM; Bafford AC
    J Surg Res; 2019 Oct; 242():118-128. PubMed ID: 31075656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gut microbiota of siblings offers insights into microbial pathogenesis of inflammatory bowel disease.
    Hedin CR; van der Gast CJ; Stagg AJ; Lindsay JO; Whelan K
    Gut Microbes; 2017 Jul; 8(4):359-365. PubMed ID: 28112583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired Autophagy in Intestinal Epithelial Cells Alters Gut Microbiota and Host Immune Responses.
    Yang L; Liu C; Zhao W; He C; Ding J; Dai R; Xu K; Xiao L; Luo L; Liu S; Li W; Meng H
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut dysbiosis in Crohn's disease: Never so close to solving the chicken-and-egg enigma: Commentary to "Gut microbiome composition is associated with future onset of Crohn's disease in healthy first-degree relatives, by Raygoza Garay JA et al., Gastroenterology 2023".
    Grellier N; Sokol H; Seksik P
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102272. PubMed ID: 38145785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
    Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in epidemiological features between ulcerative colitis and Crohn's disease: The early life-programmed versus late dysbiosis hypothesis.
    Beaugerie L; Langholz E; Nyboe-Andersen N; Pigneur B; Sokol H;
    Med Hypotheses; 2018 Jun; 115():19-21. PubMed ID: 29685190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids.
    Wang S; Martins R; Sullivan MC; Friedman ES; Misic AM; El-Fahmawi A; De Martinis ECP; O'Brien K; Chen Y; Bradley C; Zhang G; Berry ASF; Hunter CA; Baldassano RN; Rondeau MP; Beiting DP
    Microbiome; 2019 Aug; 7(1):126. PubMed ID: 31472697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Crohn's disease polymorphism,
    Lavoie S; Conway KL; Lassen KG; Jijon HB; Pan H; Chun E; Michaud M; Lang JK; Gallini Comeau CA; Dreyfuss JM; Glickman JN; Vlamakis H; Ananthakrishnan A; Kostic A; Garrett WS; Xavier RJ
    Elife; 2019 Jan; 8():. PubMed ID: 30666959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
    Libertucci J; Dutta U; Kaur S; Jury J; Rossi L; Fontes ME; Shajib MS; Khan WI; Surette MG; Verdu EF; Armstrong D
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G420-G431. PubMed ID: 29848021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysbiosis in intestinal inflammation: Cause or consequence.
    Buttó LF; Haller D
    Int J Med Microbiol; 2016 Aug; 306(5):302-309. PubMed ID: 27012594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of gut microbiota in intestinal and liver diseases.
    Hrncir T; Hrncirova L; Kverka M; Tlaskalova-Hogenova H
    Lab Anim; 2019 Jun; 53(3):271-280. PubMed ID: 30580671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.